China’s AI and Robotics Startups Race to IPO as Exit Options Vanish

China’s rapid rise in open-source AI and robotics has challenged the assumption that Silicon Valley holds an unassailable technology lead. Low-cost models, deep engineering talent and an integrated manufacturing supply chain have strengthened the sector. Yet the funding system behind those companies is markedly different from the U.S. model. Chemistry, a U.S. early-stage venture firm launched with a $350 million fund in October 2024, says China’s weak acquisition market leaves founders and investors with far fewer routes to liquidity.

After visiting China in July 2026, a Chemistry partner said local AI and robotics startups are not necessarily choosing IPOs as a strategic preference. Corporate takeovers, a common exit route in Silicon Valley, are scarce, while financing agreements often impose listing deadlines and founder share-buyback obligations. Those terms can turn a failed flotation into a personal financial burden. With M&A largely unavailable, companies are racing toward public markets because an IPO has become the dominant — and in many cases only practical — way for shareholders to exit.